Literature DB >> 20571278

Eplerenone suppresses salt-induced vascular endothelial growth factor expression in the kidney.

Danita Eatman1, Mohammed F Layas, Mohamed A Bayorh.   

Abstract

BACKGROUND/AIM: It is well accepted that high dietary salt intake accelerates both hypertension and target organ damage. We have previously shown that eplerenone attenuates sustained elevated systolic blood pressure in Dahl salt-sensitive (SS) rats. In the present study, we investigated the role of eplerenone on vascular endothelial growth factor (VEGF) expression because we suspected that eplerenone treatment may trigger a unique mechanism that relies on the downregulation of VEGF.
METHODS: Dahl SS rats were fed a high salt (8% NaCl) diet for 3 weeks and then switched to normal salt (0.3% NaCl) diet with or without treatment with eplerenone (100 mg/kg/day), enalapril (30 mg/kg/day) and their combination for an additional 3 weeks.
RESULTS: In addition to reducing blood pressure, eplerenone inhibited glomeruli sclerosis and suppressed the expression of VEGF and endothelial nitric oxide synthase mRNA as well as protein levels.
CONCLUSIONS: Based on these findings, we suggest that in part, VEGF stimulation of endothelial nitric oxide synthase plays a significant role in the eplerenone-induced reversal of the renal and vascular damage caused by high dietary salt intake.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20571278      PMCID: PMC2914374          DOI: 10.1159/000316700

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  38 in total

1.  Target organ damage in hypertension: mechanisms, prevention, and management.

Authors:  Daniel F Catanzaro; Theodore W Kurtz
Journal:  Am J Hypertens       Date:  2002-12       Impact factor: 2.689

2.  Reciprocal relation between VEGF and NO in the regulation of endothelial integrity.

Authors:  Y Tsurumi; T Murohara; K Krasinski; D Chen; B Witzenbichler; M Kearney; T Couffinhal; J M Isner
Journal:  Nat Med       Date:  1997-08       Impact factor: 53.440

3.  Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading.

Authors:  Diego V Martinez; Ricardo Rocha; Mamiko Matsumura; Eveline Oestreicher; Margarita Ochoa-Maya; Weranuj Roubsanthisuk; Gordon H Williams; Gail K Adler
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

Review 4.  Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study.

Authors:  Giuseppe Remuzzi; Manuel Macia; Piero Ruggenenti
Journal:  J Am Soc Nephrol       Date:  2006-04       Impact factor: 10.121

5.  Aldosterone induces a vascular inflammatory phenotype in the rat heart.

Authors:  Ricardo Rocha; Amy E Rudolph; Gregory E Frierdich; Denise A Nachowiak; Beverly K Kekec; Eric A G Blomme; Ellen G McMahon; John A Delyani
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-11       Impact factor: 4.733

6.  Suppression of hypoxia-associated vascular endothelial growth factor gene expression by nitric oxide via cGMP.

Authors:  N Ghiso; R M Rohan; S Amano; R Garland; A P Adamis
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-05       Impact factor: 4.799

Review 7.  Vascular protection: A novel nonangiogenic cardiovascular role for vascular endothelial growth factor.

Authors:  I Zachary; A Mathur; S Yla-Herttuala; J Martin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-06       Impact factor: 8.311

8.  Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin.

Authors:  T Murohara; J R Horowitz; M Silver; Y Tsurumi; D Chen; A Sullivan; J M Isner
Journal:  Circulation       Date:  1998 Jan 6-13       Impact factor: 29.690

Review 9.  Aldosterone and the vascular system.

Authors:  Victoria Cachofeiro; Maria Miana; Natalia de Las Heras; Beatriz Martín-Fernández; Sandra Ballesteros; Jesús Fernández-Tresguerres; Vicente Lahera
Journal:  J Steroid Biochem Mol Biol       Date:  2008-03-06       Impact factor: 4.292

Review 10.  Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies.

Authors:  Piero Ruggenenti; Paola Bettinaglio; Franck Pinares; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2008-06-11       Impact factor: 8.237

View more
  2 in total

1.  Deficiency of renal cortical EGF increases ENaC activity and contributes to salt-sensitive hypertension.

Authors:  Tengis S Pavlov; Vladislav Levchenko; Paul M O'Connor; Daria V Ilatovskaya; Oleg Palygin; Takefumi Mori; David L Mattson; Andrey Sorokin; Julian H Lombard; Allen W Cowley; Alexander Staruschenko
Journal:  J Am Soc Nephrol       Date:  2013-04-18       Impact factor: 10.121

2.  Aldosterone Increases Vascular Permeability in Rat Skin.

Authors:  Michal Aleksiejczuk; Anna Gromotowicz-Poplawska; Natalia Marcinczyk; Joanna Stelmaszewska; Janusz Dzieciol; Ewa Chabielska
Journal:  Cells       Date:  2022-08-30       Impact factor: 7.666

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.